NCT03130985View on ClinicalTrials.gov

Tissue, Blood and Biomarkers to Predict Future Atrial Fibrillation

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

May 12, 2015

Primary Completion Date

July 6, 2020

Study Completion Date

September 30, 2020

Conditions
Atrial Fibrillation
Trial Locations (1)

1105AZ

Academic Medical Center, Amsterdam

All Listed Sponsors
lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT03130985 - Tissue, Blood and Biomarkers to Predict Future Atrial Fibrillation | Biotech Hunter | Biotech Hunter